NCT00096447View on ClinicalTrials.gov

Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Recurrent Endometrial Carcinoma
Interventions
DRUG

lapatinib ditosylate

Trial Locations (1)

19103

Gynecologic Oncology Group, Philadelphia

All Listed Sponsors
collaborator

Gynecologic Oncology Group

NETWORK

lead

National Cancer Institute (NCI)

NIH

NCT00096447 - Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer | Biotech Hunter | Biotech Hunter